Associate Sponsors

Home / India News / Cadila Healthcare gets Warning Letter from USFDA

Cadila Healthcare gets Warning Letter from USFDA

Image
Capital Market
Last Updated : Dec 31 2015 | 12:47 PM IST
LinkedIN IconFacebook Icon

For its Moraiya formulation facility and Ahmedabad API facility (Zyfine)

Cadila Healthcare has received a Warning Letter issued by the US FDA relating to its Moraiya formulation facility and Ahmedabad API facility (Zyfine).

Powered by Capital Market - Live News

Connect with us on WhatsApp

More From This Section

TTK Prestige to hold board meeting

Everest Industries to hold board meeting

HT Media to hold board meeting

Pipavav Defence & Offshore Engg. Co. to hold board meeting

First Published: Dec 31 2015 | 10:22 AM IST

Explore News

Next Story